GeneProt and Waters/Micromass announce Technology Partnership

Steve Smith steve.smith at micromass.co.uk
Tue Dec 4 08:44:42 EST 2001

GeneProtT, Inc. and Waters Corporation (NYSE:WAT) today announced the
formation of a technology partnership that will result in an expansion of
the proteomics capabilities that GeneProt plans to offer to the
pharmaceutical industry through its new industrial-scale proteomics facility
in the United States. Waters, through its wholly-owned subsidiary, Micromass
U.K. Ltd., will purchase equity securities of GeneProt with a maximum value
of US$10 million. At the same time, GeneProt will purchase approximately
US$20 million of mass spectrometry equipment, related systems and services
from Micromass.

For full press release visit www.micromass.co.uk and follow the link on the

Steve Smith
Micromass UK

More information about the Proteins mailing list

Send comments to us at biosci-help [At] net.bio.net